Indivior Pharmaceuticals Inc. (INDV) vs Regencell Bioscience Holdings Limited (RGC)
- Indivior Pharmaceuticals Inc. INDV 32.45 −3.48%
- Regencell Bioscience Holdings Limited RGC 9.59 +0.74%
Indivior Pharmaceuticals Inc. and Regencell Bioscience Holdings Limited are both Drug Manufacturers Specialty & Generic companies. Regencell Bioscience Holdings Limited is the larger, with a market value of $4.7B against $4.0B — 1.2× the size. Regencell Bioscience Holdings Limited has negative trailing earnings, so its P/E is not meaningful; Indivior Pharmaceuticals Inc. trades at 11.2×. Indivior Pharmaceuticals Inc. has the higher net margin (26.8% vs 0.00%) and the higher return on invested capital (460.5% vs 0.00%). Across the 12 metrics below, Indivior Pharmaceuticals Inc. leads on 7 and Regencell Bioscience Holdings Limited on 5.
Valuation
Profitability
| Metric | INDV | RGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 81.97% | — | 53.94% |
| Operating margin | 31.56% | — | 0.00% |
| Net margin | 26.75% | 0.00% | 0.00% |
| Free cash flow margin | (8.34%) | 0.00% | 0.00% |
| Return on equity | (153.12%) | 0.00% | (0.40%) |
| Return on assets | 26.52% | 0.00% | (3.32%) |
| Return on invested capital | 460.53% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack